T1	SectionAnnotate 2 13	SUBJECTIVE:
T2	SectionSkip 2797 2817	CURRENT MEDICATIONS:
T3	SectionSkip 2819 7036	Current Outpatient Medications on File Prior to Visit   Medication Sig Dispense Refill    albuterol 90 mcg/actuation metered dose inhaler Inhale 2 puffs into the lungs every 4 (four) hours as needed    (Patient not taking: Reported on 06/20/2022)      buPROPion 450 mg TABSR24H Take 450 mg by mouth daily      capecitabine (XELODA) 500 mg tablet Take 3 tabs with food in the morning, and take 3 tabs with food in the evening. Take for 7 days and then off for 7 days. (Patient not taking: Reported on 06/20/2022) 84 tablet 5    clonazePAM (KLONOPIN) 1 mg tablet Take 1 mg by mouth 2 (two) times daily as needed      clotrimazole (LOTRIMIN) 1 % cream Apply topically Twice a day Use as instructed apply to sides of mouth/lips      cyanocobalamin 2,500 mcg SL tablet 2,500 mcg      cyclobenzaprine (FLEXERIL) 10 mg tablet   1 Tab, PO TID, PRN AS NEEDED, Qty: 90 Tab, Refills: 2, ***** ***** ***** Electronically, ***** ***** *****, 30      diclofenac (VOLTAREN) 1 % gel Apply topically 4 (four) times daily as needed      etodolac (*****) 400 mg tablet Take 400 
 mg by mouth 2 (two) times daily      famotidine (PEPCID) 20 mg tablet Take 1 tablet (20 mg total) by mouth in the morning and 1 tablet (20 mg total) in the evening. (Patient taking differently: Take 40 mg by mouth in the morning and 40 mg at noon and 40 mg in the evening.) 180 tablet 2    FLUoxetine (PROZAC) 40 mg capsule Take 40 mg by mouth daily      fluticasone propionate (FLOVENT DISKUS INH) Inhale into the lungs (Patient not taking: Reported on 06/20/2022)      gabapentin (NEURONTIN) 300 mg capsule Take 1,200 mg by mouth 2 (two) times daily      hydrocortisone 2.5 % ointment Apply topically 4 (four) times daily      levocarnitine HCl (ACETYL-L-CARNITINE MISC) Take 1 tablet by mouth daily      lidocaine-diphenhydrAMINE-maalox (MAGIC MOUTHWASH) mouthwash Use as directed 10 mL in the mouth or throat in the morning and 10 mL at noon and 10 mL in the evening and 10 mL before bedtime. For mouth sores.. 480 mL 1    lipase-protease-amylase (CREON) 24,000-76,000 -120,000 unit capsule Take 1 to 2 caps with meals, take 1 cap with snacks 180 capsule 11    loperamide (IMODIUM) 2 mg capsule Take two capsules by mouth at the onset of diarrhea, then take one capsule every 2 hours until diarrhea-free for 12 hours. (Patient not taking: Reported on 06/20/2022) 30 capsule 5    LORazepam (ATIVAN) 1 mg tablet Take 1 mg by mouth nightly as needed for Anxiety         losartan (COZAAR) 50 mg tablet Take 50 mg by mouth every evening (Patient not taking: Reported on 06/20/2022)      montelukast (SINGULAIR) 10 mg tablet Take 10 mg by mouth daily      multivitamin tablet Take 1 tablet by mouth daily      naloxone 4 mg/actuation SPRAYNAERO 1 spray by Nasal route once as needed (suspected overdose) for up to 1 dose Call 911. Repeat if needed (Patient not taking: Reported on 06/20/2022) 2 each 0    ondansetron (ZOFRAN) 8 mg tablet Take 1 tablet (8 mg total) by mouth every 8 (eight) hours as needed (nausea and vomiting) (Patient not 
 taking: Reported on 06/20/2022) 30 tablet 5    oxyCODONE (ROXICODONE) 5 mg tablet Take 1 tablet (5 mg total) by mouth every 8 (eight) hours as needed for Pain (Pain not relieved by gabapentin, tylenol or ibuprofen) (Patient not taking: Reported on 06/20/2022) 10 tablet 0    polyethylene glycol (MIRALAX) 17 gram packet Take 17 g by mouth as needed in the morning (constipation). (Patient not taking: Reported on 06/20/2022)      prochlorperazine (COMPAZINE) 10 mg tablet Take 1 tablet (10 mg total) by mouth every 6 (six) hours as needed (nausea and vomiting) (Patient not taking: Reported on 06/20/2022) 30 tablet 5    rOPINIRole (REQUIP) 1 mg tablet Take 1 mg by mouth nightly at bedtime      tamsulosin (FLOMAX) 0.4 mg 24 hr capsule Take 1 capsule (0.4 mg total) by mouth daily 30 capsule 1    thyroid, porcine, (ARMOUR) 120 mg tablet 120 mg daily      UNABLE TO FIND 28 mg daily Med Name: ferrous  bis-glycinate      VITAMIN B-1, MONONITRATE, 100 mg tablet Take 100 mg by mouth daily (Patient not taking: Reported on 06/20/2022)      zolpidem (AMBIEN) 10 mg tablet Take 10 mg by mouth nightly as needed       No current facility-administered medications on file prior to visit.
T4	SectionSkip 7041 7051	ALLERGIES:
T5	SectionAnnotate 7153 7168	FAMILY HISTORY:
T6	SectionAnnotate 7277 7292	SOCIAL HISTORY:
T7	SectionSkip 7738 9241	LABORATORY RESULTS:  Results for orders placed or 
 performed in visit on 06/21/22   Comprehensive Metabolic Panel, Random (BMP, AST, ALT, T.BILI, ALKP, TP, ALB)   Result Value Ref Range    Albumin, Serum / Plasma 3.4 3.4 - 4.8 g/dL    Alkaline Phosphatase 151 (H) 38 - 108 U/L    Alanine transaminase 29 10 - 61 U/L    AST 24 5 - 44 U/L    Bilirubin, Total 0.3 0.2 - 1.2 mg/dL    Urea Nitrogen, Serum / Plasma 12 7 - 25 mg/dL    Calcium, total, Serum / Plasma 9.3 8.4 - 10.5 mg/dL    Chloride, Serum / Plasma 99 (L) 101 - 110 mmol/L    Creatinine 0.82 0.55 - 1.02 mg/dL    ***** 79 >59 mL/min/1.73m2    Potassium, Serum / Plasma 5.3 (H) 3.5 - 5.0 mmol/L    Sodium, Serum / Plasma 129 (L) 135 - 145 mmol/L    Protein, Total, Serum / Plasma 6.8 6.3 - 8.6 g/dL    Carbon Dioxide, Total 25 22 - 29 mmol/L    Anion Gap 5 4 - 14    Glucose, non-fasting 109 70 - 199 mg/dL   Complete Blood Count with 5-part Differential   Result Value Ref Range    WBC Count 11.7 (H) 3.4 - 10.0 x10E9/L    RBC Count 3.34 (L) 4.00 - 5.20 x10E12/L    Hemoglobin 11.5 (L) 12.0 - 15.5 g/dL    Hematocrit 34.3 (L) 36.0 - 46.0 %    MCV 103 (H) 80 - 100 fL    MCH 34.4 (H) 26.0 - 34.0 pg    MCHC 33.5 31.0 - 36.0 g/dL    Platelet Count 485 (H) 140 - 450 x10E9/L    Abs Neutrophils 5.24 1.80 - 6.80 x10E9/L    Abs Lymphocytes 2.75 1.00 - 3.40 x10E9/L    Abs Monocytes 2.59 (H) 0.20 - 0.80 x10E9/L    Abs Eosinophils 0.93 (H) 0.00 - 0.40 x10E9/L    Abs Basophils 0.04 0.00 - 0.10 x10E9/L    Abs Imm Granulocytes 0.13 (H) <0.10 x10E9/L
T8	SectionSkip 9248 9384	IMAGING:  CT Abdomen /Pelvis with Contrast    Result Date: 06/19/2022  CT ABDOMEN/PELVIS WITH CONTRAST  *****/*****/***** *****:***** PM
T9	SectionSkip 9540 9772	MEDICATIONS: Iohexol 350 - 110 mL - Intravenous RADIATION DOSE INDICATORS: ***** *****: 3 , CTDIvol Min: 7.9 mGy, CTDIvol Max: 7.9 mGy, DLP: 504.5 mGy.cm. The following accession numbers are related to this dose 
 report *****,*****
T10	SectionSkip 9773 11814	FINDINGS: Visualized lung bases:  For chest findings, please see the separately dictated report from the CT of the chest of the same date. Liver:  Unremarkable Gallbladder: Unremarkable Spleen:  Status post splenectomy. Pancreas:  Expected postsurgical changes related to prior distal pancreatectomy of the body and tail. Adrenal Glands:  Unremarkable Kidneys: Subcentimeter bilateral hypodensities too small to definitively characterize, likely cysts, unchanged. GI Tract:  Small hiatal hernia, unchanged. Vasculature:  - Decrease in stranding surrounding the celiac axis and branches, reflecting expected postoperative changes. - Interval resolution of previously noted narrowing of the junction of the portal vein and superior mesenteric vein. - Mild atherosclerotic disease of the abdominal aorta and its branches. Lymphadenopathy: Unchanged gastrohepatic lymph node measuring 9 x 7 mm, may be reactive secondary to prior surgery. Peritoneum: No ascites. Interval resolution of previously seen trace free fluid adjacent to the cut edge of pancreas. Bladder: Unremarkable Reproductive organs: Intrauterine device in place. Leiomyoma. Bones:  No suspicious lesions. Redemonstrated bilateral pars defects at L5, and degenerative disc disease at L5/S1 with grade 1 anterolisthesis. Extraperitoneal soft tissues: Unremarkable Lines/drains/medical devices: As above     1. Expected postsurgical changes related to prior distal pancreatectomy of the body and tail. 2. No evidence of metastatic disease in the abdomen or pelvis. Report dictated by: ***** *****, MD, signed by: ***** *****-***** *****, MD Department of Radiology and Biomedical Imaging    CT Chest with Contrast    Addendum Date: 06/19/2022    //Segmental/subsegmental right lower lobe pulmonary embolism discussed with Ong, RN by ***** ***** *****, MD (Radiology) on *****/*****/***** *****:***** PM.// Report dictated by: ***** ***** *****, MD, signed by: ***** ***** *****, MD 
 Department of Radiology and Biomedical Imaging    Result Date: 06/19/2022  CT CHEST WITH CONTRAST
T11	SectionSkip 12260 13092	FINDINGS: LUNGS: Unchanged left lower lobe pulmonary nodule (December 301). No new or enlarging pulmonary nodules. PLEURA: No pleural effusion or pneumothorax. MEDIASTINUM: No suspicious lymphadenopathy. HEART/GREAT VESSELS: The heart is normal in size without evidence of pericardial effusion. No significant coronary artery atherosclerotic calcifications. Normal caliber thoracic aorta and main pulmonary artery. Pulmonary embolism within the segmental and subsegmental right lower lobe pulmonary arteries. BONES/SOFT TISSUES: No suspicious osseous lesions. VISIBLE ABDOMEN: Please see dedicated Abdomen and Pelvis CT report.     Tiny left lower lobe pulmonary nodule. No new or enlarging pulmonary nodules. Report dictated by: ***** ***** *****, MD, signed by: ***** ***** *****, MD Department of Radiology and Biomedical Imaging
T12	SectionAnnotate 13099 13110	ASSESSMENT:
T13	PROBLEM 114 123	pneumonia
T14	TEST 125 145	An abdominal CT scan
T15	PROBLEM 206 251	a pancreatic mass in the tail of the pancreas
T16	TEST 253 287	Fine needle aspiration of the mass
T17	TEST 291 294	EUS
T18	PROBLEM 302 316	adenocarcinoma
T19	TEST 343 370	a pancreas protocol CT scan
T20	PROBLEM 415 433	metastatic disease
T21	PROBLEM 435 471	The mass in the distal necrotic body
T22	TREATMENT 696 715	neoadjuvant therapy
T23	TREATMENT 736 747	gemcitabine
T24	TREATMENT 752 760	Abraxane
T25	PROBLEM 829 850	severe adverse events
T26	PROBLEM 861 884	metabolic abnormalities
T27	PROBLEM 890 903	hypercalcemia
T28	PROBLEM 908 920	hyponatremia
T29	PROBLEM 932 948	total body aches
T30	TREATMENT 1019 1039	preoperative therapy
T31	TREATMENT 1058 1065	surgery
T32	TREATMENT 1097 1120	a distal pancreatectomy
T33	TREATMENT 1125 1136	splenectomy
T34	PROBLEM 1160 1202	a moderately differentiated adenocarcinoma
T35	PROBLEM 1234 1248	29 lymph nodes
T36	PROBLEM 1308 1320	an infection
T37	PROBLEM 1325 1332	abscess
T38	TEST 1348 1352	ERCP
T39	TREATMENT 1357 1365	drainage
T40	TREATMENT 1385 1410	postoperative gemcitabine
T41	TREATMENT 1415 1427	capecitabine
T42	TREATMENT 1434 1460	an alternate week schedule
T43	PROBLEM 1529 1538	mucositis
T44	Symptom 1543 1568	severe hand-foot syndrome
T45	Symptom 1574 1597	cracking and blistering
T46	TREATMENT 1615 1632	dose modification
T47	Symptom 1707 1714	vertigo
T48	TREATMENT 1765 1773	a walker
T49	PROBLEM 1785 1798	very fatigued
T50	PROBLEM 1938 1958	musculoskeletal pain
T51	MedicationName 1969 1976	Tylenol
T52	MedicationName 1978 1986	Flexeril
T53	MedicationName 1991 2001	gabapentin
T54	TEST 2137 2157	some genetic testing
T55	PROBLEM 2255 2267	Hypertension
T56	ClinicalCondition 2280 2294	hypothyroidism
T57	ClinicalCondition 2296 2302	asthma
T58	TREATMENT 2314 2335	frequent intervention
T59	PROBLEM 2337 2368	depression  psoriatic arthritis
T60	PROBLEM 2396 2417	restless leg syndrome
T61	PROBLEM 2419 2423	GERD
T62	PROBLEM 2436 2455	Barrett's esophagus
T63	PROBLEM 2466 2472	stroke
T64	PROBLEM 2480 2506	MRSA infection right elbow
T65	TREATMENT 2516 2531	PRIOR SURGERIES
T66	PROBLEM 2534 2553	Metatarsal fracture
T67	TREATMENT 2564 2571	surgery
T68	TREATMENT 2576 2597	placement of hardware
T69	TREATMENT 2605 2633	right total knee replacement
T70	PROBLEM 2649 2687	MRSA infection  left clavicle fracture
T71	TREATMENT 2698 2705	surgery
T72	PROBLEM 2743 2758	Broken clavicle
T73	TREATMENT 2819 2849	Current Outpatient Medications
T74	TREATMENT 2910 2919	albuterol
T75	TREATMENT 3073 3082	buPROPion
T76	TREATMENT 3132 3153	capecitabine (XELODA)
T77	TREATMENT 3350 3371	clonazePAM (KLONOPIN)
T78	TREATMENT 3439 3462	clotrimazole (LOTRIMIN)
T79	TREATMENT 3537 3547	mouth/lips
T80	TREATMENT 3554 3568	cyanocobalamin
T81	TREATMENT 3605 3631	cyclobenzaprine (FLEXERIL)
T82	TREATMENT 3764 3785	diclofenac (VOLTAREN)
T83	TREATMENT 3847 3863	etodolac (*****)
T84	TREATMENT 3927 3946	famotidine (PEPCID)
T85	TREATMENT 4181 4200	FLUoxetine (PROZAC)
T86	TREATMENT 4247 4290	fluticasone propionate (FLOVENT DISKUS INH)
T87	TREATMENT 4364 4386	gabapentin (NEURONTIN)
T88	TREATMENT 4451 4465	hydrocortisone
T89	TREATMENT 4524 4567	levocarnitine HCl (ACETYL-L-CARNITINE MISC)
T90	TREATMENT 4603 4663	lidocaine-diphenhydrAMINE-maalox (MAGIC MOUTHWASH) mouthwash
T91	PROBLEM 4797 4808	mouth sores
T92	TREATMENT 4824 4855	lipase-protease-amylase (CREON)
T93	TREATMENT 4963 4983	loperamide (IMODIUM)
T94	PROBLEM 5040 5048	diarrhea
T95	TREATMENT 5182 5200	LORazepam (ATIVAN)
T96	PROBLEM 5254 5261	Anxiety
T97	TREATMENT 5271 5288	losartan (COZAAR)
T98	TREATMENT 5387 5410	montelukast (SINGULAIR)
T99	TREATMENT 5456 5468	multivitamin
T100	TREATMENT 5511 5519	naloxone
T101	TREATMENT 5707 5727	ondansetron (ZOFRAN)
T102	PROBLEM 5809 5815	nausea
T103	PROBLEM 5820 5828	vomiting
T104	TREATMENT 5893 5915	oxyCODONE (ROXICODONE)
T105	PROBLEM 6000 6010	Pain (Pain
T106	TREATMENT 6027 6037	gabapentin
T107	TREATMENT 6039 6046	tylenol
T108	TREATMENT 6050 6059	ibuprofen
T109	TREATMENT 6122 6151	polyethylene glycol (MIRALAX)
T110	PROBLEM 6212 6224	constipation
T111	TREATMENT 6278 6306	prochlorperazine (COMPAZINE)
T112	PROBLEM 6388 6394	nausea
T113	PROBLEM 6399 6407	vomiting
T114	TREATMENT 6470 6489	rOPINIRole (REQUIP)
T115	TREATMENT 6546 6565	tamsulosin (FLOMAX)
T116	TREATMENT 6775 6799	VITAMIN B-1, MONONITRATE
T117	TREATMENT 6893 6910	zolpidem (AMBIEN)
T118	TREATMENT 7001 7012	medications
T119	PROBLEM 7053 7062	Allergies
T120	TREATMENT 7083 7101	Allergen Reactions
T121	TREATMENT 7106 7136	Sulfa (Sulfonamide Antibiotics
T122	PROBLEM 7138 7146	Swelling
T123	PROBLEM 7185 7200	prostate cancer
T124	PROBLEM 7232 7245	breast cancer
T125	PROBLEM 7542 7553	very active
T126	PROBLEM 7620 7629	arthritis
T127	TEST 7665 7671	vitals
T128	TEST 7837 7852	Metabolic Panel
T129	TEST 7862 7865	BMP
T130	TEST 7867 7870	AST
T131	TEST 7872 7875	ALT
T132	TEST 7877 7883	T.BILI
T133	TEST 7885 7889	ALKP
T134	TEST 7891 7893	TP
T135	TEST 7895 7898	ALB
T136	TEST 7909 7914	Value
T137	TEST 7919 7924	Range
T138	TEST 7928 7935	Albumin
T139	TEST 7937 7942	Serum
T140	TEST 7945 7951	Plasma
T141	TEST 7974 7994	Alkaline Phosphatase
T142	TEST 8012 8039	U/L    Alanine transaminase
T143	TEST 8051 8061	U/L    AST
T144	TEST 8072 8088	U/L    Bilirubin
T145	TEST 8090 8095	Total
T146	TEST 8119 8132	Urea Nitrogen
T147	TEST 8134 8139	Serum
T148	TEST 8142 8148	Plasma
T149	TEST 8168 8175	Calcium
T150	TEST 8184 8189	Serum
T151	TEST 8192 8198	Plasma
T152	TEST 8223 8231	Chloride
T153	TEST 8233 8238	Serum
T154	TEST 8241 8247	Plasma
T155	TEST 8265 8271	mmol/L
T156	TEST 8275 8285	Creatinine
T157	TEST 8303 8308	mg/dL
T158	TEST 8342 8351	Potassium
T159	TEST 8353 8358	Serum
T160	TEST 8361 8367	Plasma
T161	TEST 8386 8390	mmol
T162	TEST 8396 8402	Sodium
T163	TEST 8404 8409	Serum
T164	TEST 8412 8418	Plasma
T165	TEST 8437 8441	mmol
T166	TEST 8447 8454	Protein
T167	TEST 8456 8461	Total
T168	TEST 8463 8468	Serum
T169	TEST 8471 8477	Plasma
T170	TEST 8492 8496	g/dL
T171	TEST 8500 8514	Carbon Dioxide
T172	TEST 8516 8521	Total
T173	TEST 8543 8552	Anion Gap
T174	TEST 8565 8572	Glucose
T175	TEST 8574 8585	non-fasting
T176	TEST 8607 8627	Complete Blood Count
T177	TEST 8662 8667	Value
T178	TEST 8672 8677	Range
T179	TEST 8681 8690	WBC Count
T180	TEST 8697 8698	H
T181	TEST 8722 8731	RBC Count
T182	TEST 8738 8739	L
T183	TEST 8765 8775	Hemoglobin
T184	TEST 8797 8801	g/dL
T185	TEST 8805 8815	Hematocrit
T186	TEST 8822 8823	L
T187	TEST 8842 8845	MCV
T188	TEST 8869 8872	MCH
T189	TEST 8894 8896	pg
T190	TEST 8900 8904	MCHC
T191	TEST 8922 8926	g/dL
T192	TEST 8930 8944	Platelet Count
T193	TEST 8950 8951	H
T194	TEST 8963 8968	x10E9
T195	TEST 8974 8977	Abs
T196	TEST 8978 8989	Neutrophils
T197	TEST 9007 9012	x10E9
T198	TEST 9018 9021	Abs
T199	TEST 9022 9033	Lymphocytes
T200	TEST 9051 9056	x10E9
T201	TEST 9066 9075	Monocytes
T202	TEST 9082 9083	H
T203	TEST 9112 9123	Eosinophils
T204	TEST 9130 9131	H
T205	TEST 9156 9159	Abs
T206	TEST 9160 9169	Basophils
T207	TEST 9206 9218	Granulocytes
T208	TEST 9240 9255	L       IMAGING
T209	TEST 9258 9290	CT Abdomen /Pelvis with Contrast
T210	TEST 9319 9321	CT
T211	TEST 9322 9350	ABDOMEN/PELVIS WITH CONTRAST
T212	TEST 9403 9420	surveillance scan
T213	PROBLEM 9425 9442	pancreatic cancer
T214	TEST 9456 9473	CT abdomen/pelvis
T215	TEST 9496 9524	CT of the abdomen and pelvis
T216	TREATMENT 9553 9560	Iohexol
T217	TEST 9654 9665	CTDIvol Max
T218	TEST 9676 9679	DLP
T219	TEST 9811 9825	chest findings
T220	TEST 9874 9893	the CT of the chest
T221	TREATMENT 9980 9991	splenectomy
T222	PROBLEM 10004 10033	Expected postsurgical changes
T223	TREATMENT 10045 10093	prior distal pancreatectomy of the body and tail
T224	PROBLEM 10134 10171	Subcentimeter bilateral hypodensities
T225	PROBLEM 10219 10224	cysts
T226	PROBLEM 10248 10267	Small hiatal hernia
T227	PROBLEM 10296 10317	Decrease in stranding
T228	PROBLEM 10371 10401	expected postoperative changes
T229	PROBLEM 10428 10454	previously noted narrowing
T230	PROBLEM 10522 10590	Mild atherosclerotic disease of the abdominal aorta and its branches
T231	PROBLEM 10592 10607	Lymphadenopathy
T232	PROBLEM 10609 10643	Unchanged gastrohepatic lymph node
T233	PROBLEM 10671 10679	reactive
T234	TREATMENT 10693 10706	prior surgery
T235	PROBLEM 10723 10730	ascites
T236	PROBLEM 10771 10787	trace free fluid
T237	TREATMENT 10869 10888	Intrauterine device
T238	PROBLEM 10899 10908	Leiomyoma
T239	PROBLEM 10921 10939	suspicious lesions
T240	PROBLEM 10941 10984	Redemonstrated bilateral pars defects at L5
T241	PROBLEM 10990 11024	degenerative disc disease at L5/S1
T242	PROBLEM 11030 11053	grade 1 anterolisthesis
T243	TREATMENT 11085 11110	Unremarkable Lines/drains
T244	PROBLEM 11144 11173	Expected postsurgical changes
T245	TREATMENT 11185 11233	prior distal pancreatectomy of the body and tail
T246	PROBLEM 11253 11296	metastatic disease in the abdomen or pelvis
T247	TEST 11402 11432	Biomedical Imaging    CT Chest
T248	PROBLEM 11479 11539	//Segmental/subsegmental right lower lobe pulmonary embolism
T249	TEST 11792 11794	CT
T250	PROBLEM 11834 11851	Pancreatic cancer
T251	TEST 11853 11878	primary surveillance scan
T252	TEST 11891 11899	CT chest
T253	TEST 11928 11973	Serial 1.25 mm axial images through the chest
T254	TREATMENT 12016 12036	intravenous contrast
T255	TREATMENT 12038 12045	Iohexol
T256	TEST 12143 12154	CTDIvol Max
T257	TEST 12165 12168	DLP
T258	PROBLEM 12277 12319	Unchanged left lower lobe pulmonary nodule
T259	PROBLEM 12339 12373	new or enlarging pulmonary nodules
T260	PROBLEM 12386 12402	pleural effusion
T261	PROBLEM 12406 12418	pneumothorax
T262	PROBLEM 12436 12462	suspicious lymphadenopathy
T263	PROBLEM 12533 12553	pericardial effusion
T264	PROBLEM 12558 12616	significant coronary artery atherosclerotic calcifications
T265	PROBLEM 12675 12693	Pulmonary embolism
T266	PROBLEM 12792 12818	suspicious osseous lesions
T267	TEST 12848 12879	dedicated Abdomen and Pelvis CT
T268	PROBLEM 12892 12929	Tiny left lower lobe pulmonary nodule
T269	PROBLEM 12934 12968	new or enlarging pulmonary nodules
T270	PROBLEM 13115 13157	Adenocarcinoma of the tail of the pancreas
T271	TREATMENT 13171 13192	distal pancreatectomy
T272	TREATMENT 13197 13208	splenectomy
T273	PROBLEM 13214 13234	positive lymph nodes
T274	ClinicalCondition 13240 13259	Psoriatic arthritis
T275	ClinicalCondition 13264 13278	Chronic asthma
T276	ClinicalCondition 13283 13295	Hypertension
T277	PROBLEM 13311 13325	MRSA infection
T278	TEST 13333 13337	ECOG
T279	ClinicalCondition 13344 13356	Hyponatremia
T280	ClinicalCondition 13381 13394	Incidental PE
T281	PROBLEM 13411 13425	frequent falls
T282	PROBLEM 13442 13457	loss of balance
T283	PROBLEM 13463 13488	Severe hand-foot syndrome
T284	PROBLEM 13493 13502	mucositis
T285	TREATMENT 13516 13528	chemotherapy
T286	TREATMENT 13560 13576	her chemotherapy
T287	PROBLEM 13605 13627	her hand-foot syndrome
T288	TREATMENT 13649 13658	treatment
T289	PROBLEM 13706 13715	her falls
T290	TEST 13733 13749	a CT of the head
T291	TREATMENT 13793 13809	the capecitabine
T292	PROBLEM 13829 13847	a balance disorder
T293	TREATMENT 13881 13890	treatment
T294	TREATMENT 13948 13956	a walker
T295	PROBLEM 13976 13982	her PE
T296	TREATMENT 14005 14012	Lovenox
T297	TEST 14031 14039	Dopplers
T298	PROBLEM 14070 14073	DVT
T299	TREATMENT 14106 14113	Lovenox
T300	TEST 14157 14172	this evaluation
T301	TEST 14348 14363	this evaluation
T302	TEST 14370 14386	telehealth tools
T303	TREATMENT 14424 14443	this patient's care
T304	TREATMENT 14502 14523	any billed procedures
T305	TEST 14661 14666	tests
T306	Age 39 41	65
T307	ClinicalCondition 114 123	pneumonia
A1	ChronicVal T307 non-chronic
A2	ContinuityVal T307 stopped
A3	ExperiencerVal T307 patient
T308	Radiology 128 145	abdominal CT scan
A4	IntentVal T308 others
T309	RadPathResult 208 223	pancreatic mass
A5	IntentVal T309 others
A6	RadPathResultVal T309 InitialCancerDiagnosis
R1	ResultOfTest Desc:T309 Test:T308	
T310	Site 231 251	tail of the pancreas
R2	SiteOf Arg1:T310 Arg2:T309	
T311	ProcedureName 253 275	Fine needle aspiration
A7	IntentVal T311 diagnosis
A8	IsTumorRemaining T311 yes
T312	ProcedureName 291 294	EUS
A9	IntentVal T312 diagnosis
T313	Histology 302 316	adenocarcinoma
A10	EpisodeDescription T313 FirstOccurrence
R3	TestOrProcedureReveals Test:T311 Desc:T313	
T314	Radiology 345 370	pancreas protocol CT scan
A11	IntentVal T314 staging
T315	Metastasis 415 433	metastatic disease
A12	NegationModalityVal T315 negated
R4	TestOrProcedureReveals Test:T314 Desc:T315	
T316	RadPathResult 439 443	mass
A13	RadPathResultVal T316 InitialCancerDiagnosis
T317	Site 451 471	distal necrotic body
R5	SiteOf Arg1:T317 Arg2:T316	
T318	Size 481 487	3.9 cm
A14	EpisodeDescription T318 FirstOccurrence
R6	ResultOfTest Desc:T316 Test:T314	
T319	LocalInvasion 495 520	localized to the pancreas
A15	NegationModalityVal T319 negated
A16	EpisodeDescription T319 FirstOccurrence
R7	TestOrProcedureReveals Test:T314 Desc:T319	
T320	LocalInvasion 644 654	resectable
A17	NegationModalityVal T320 negated
A18	EpisodeDescription T320 FirstOccurrence
T321	TreatmentType 696 715	neoadjuvant therapy
A19	NegationModalityVal T321 hypothetical_in_future
A20	TreatmentTypeVal T321 neoadjuvant
A21	TreatmentIntentVal T321 curative
T322	MedicationRegimen 736 760	gemcitabine and Abraxane
A22	TreatmentContinuityVal T322 started
A23	TreatmentTypeVal T322 neoadjuvant
A24	TreatmentIntentVal T322 curative
T323	Cycles 780 781	2
R8	TreatmentDesc Therapy:T323 Desc:T322	
T324	Symptom 861 884	metabolic abnormalities
A25	IsPresentOnFirstCancerDiagnosis T324 no
A26	IsCausedByDiagnosedCancer T324 no
A27	ChronicVal T324 non-chronic
A28	ContinuityVal T324 stopped
T325	Symptom 890 903	hypercalcemia
A29	IsPresentOnFirstCancerDiagnosis T325 no
A30	IsCausedByDiagnosedCancer T325 no
A31	ChronicVal T325 non-chronic
A32	ContinuityVal T325 stopped
T326	Symptom 908 920	hyponatremia
A33	IsPresentOnFirstCancerDiagnosis T326 no
A34	IsCausedByDiagnosedCancer T326 no
A35	ChronicVal T326 non-chronic
A36	ContinuityVal T326 stopped
T327	Symptom 932 948	total body aches
A37	IsPresentOnFirstCancerDiagnosis T327 no
A38	IsCausedByDiagnosedCancer T327 no
A39	ChronicVal T327 non-chronic
A40	ContinuityVal T327 stopped
R9	TreatmentDiscontinuedBecauseOf Therapy:T322 Reason:T324	
R10	TreatmentDiscontinuedBecauseOf Therapy:T322 Reason:T325	
R11	TreatmentDiscontinuedBecauseOf Therapy:T322 Reason:T326	
R12	TreatmentDiscontinuedBecauseOf Therapy:T322 Reason:T327	
T328	TreatmentType 1019 1039	preoperative therapy
A41	TreatmentContinuityVal T328 discontinued_early
A42	TreatmentTypeVal T328 neoadjuvant
A43	TreatmentIntentVal T328 curative
T329	TreatmentType 1058 1065	surgery
A44	TreatmentContinuityVal T329 finished
A45	TreatmentTypeVal T329 local
A46	TreatmentIntentVal T329 curative
T330	Datetime 1073 1081	03/01/22
T331	ProcedureName 1099 1136	distal pancreatectomy and splenectomy
A47	TreatmentContinuityVal T331 finished
A48	TreatmentTypeVal T331 local
A49	TreatmentIntentVal T331 curative
R13	HappensAtOnDuring Arg1:T330 Arg2:T331	
T332	Histology 1188 1202	adenocarcinoma
A50	EpisodeDescription T332 FirstOccurrence
T333	Grade 1162 1187	moderately differentiated
A51	EpisodeDescription T333 FirstOccurrence
A52	IntentVal T331 treatment-curative
A53	TreatmentCategory T331 AntiNeoPlastics
A54	IsTumorRemaining T331 no
R14	TestOrProcedureReveals Test:T331 Desc:T333	
R15	TestOrProcedureReveals Test:T331 Desc:T332	
T334	MarginStatus 1217 1224	margins
A55	MarginVal T334 MoreThan2mm(Neg)
R16	ProcedureDesc Procedure:T334 Desc:T331	
T335	LymphNodeInvolvement 1229 1236	2 of 29
A56	EpisodeDescription T335 FirstOccurrence
R17	TestOrProcedureReveals Test:T331 Desc:T335	
T336	ClinicalCondition 1311 1320	infection
A57	ChronicVal T336 non-chronic
A58	ContinuityVal T336 stopped
T337	ClinicalCondition 1325 1332	abscess
A59	ChronicVal T337 non-chronic
A60	ContinuityVal T337 stopped
T338	ProcedureName 1348 1352	ERCP
A61	IntentVal T338 others
A62	TreatmentTypeVal T338 others
A63	TreatmentCategory T338 Others
R18	TestOrProcedureConductedForProblem Test:T338 Prob:T337	
R19	TestOrProcedureConductedForProblem Test:T338 Prob:T336	
T339	MedicationRegimen 1399 1427	gemcitabine and capecitabine
A64	TreatmentContinuityVal T339 continuing
A65	TreatmentTypeVal T339 adjuvant
A66	TreatmentIntentVal T339 curative
T340	Frequency 1437 1451	alternate week
R20	Temporal Arg1:T339 Arg2:T340	
T341	Cycles 1474 1475	2
R21	TreatmentDesc Therapy:T341 Desc:T339	
T342	Symptom 1529 1538	mucositis
A67	IsPresentOnFirstCancerDiagnosis T342 no
A68	IsCausedByDiagnosedCancer T342 no
A69	ChronicVal T342 non-chronic
A70	ContinuityVal T342 unclear
A71	IsPresentOnFirstCancerDiagnosis T44 no
A72	IsCausedByDiagnosedCancer T44 no
A73	ChronicVal T44 non-chronic
A74	ContinuityVal T44 unclear
A75	IsPresentOnFirstCancerDiagnosis T45 no
A76	IsCausedByDiagnosedCancer T45 no
A77	ChronicVal T45 non-chronic
A78	ContinuityVal T45 unclear
R22	ConditionOrTreatmentCausesProblem Treatment:T339 Prob:T342	
R23	ConditionOrTreatmentCausesProblem Treatment:T339 Prob:T44	
R24	ConditionOrTreatmentCausesProblem Treatment:T339 Prob:T45	
T343	Symptom 1650 1657	falling
A79	IsPresentOnFirstCancerDiagnosis T343 no
A80	IsCausedByDiagnosedCancer T343 no
A81	ChronicVal T343 non-chronic
A82	ContinuityVal T343 unclear
A83	IsPresentOnFirstCancerDiagnosis T47 no
A84	IsCausedByDiagnosedCancer T47 no
A85	ChronicVal T47 non-chronic
A86	ContinuityVal T47 unclear
A87	NegationModalityVal T47 negated
T344	Symptom 1729 1745	lose her balance
A88	IsPresentOnFirstCancerDiagnosis T344 no
A89	IsCausedByDiagnosedCancer T344 no
A90	ChronicVal T344 non-chronic
A91	ContinuityVal T344 unclear
T345	Symptom 1790 1798	fatigued
A92	IsPresentOnFirstCancerDiagnosis T345 no
A93	IsCausedByDiagnosedCancer T345 no
A94	ChronicVal T345 non-chronic
A95	ContinuityVal T345 worsening
T346	Symptom 1938 1958	musculoskeletal pain
A96	IsPresentOnFirstCancerDiagnosis T346 no
A97	IsCausedByDiagnosedCancer T346 no
A98	ChronicVal T346 non-chronic
A99	ContinuityVal T346 unclear
A100	TreatmentContinuityVal T51 continuing
A101	TreatmentTypeVal T51 others
A102	TreatmentIntentVal T51 others
A103	TreatmentCategory T51 Supportive
A104	TreatmentContinuityVal T52 continuing
A105	TreatmentTypeVal T52 others
A106	TreatmentIntentVal T52 others
A107	TreatmentCategory T52 Supportive
A108	TreatmentContinuityVal T53 continuing
A109	TreatmentTypeVal T53 others
A110	TreatmentIntentVal T53 others
A111	TreatmentCategory T53 Supportive
R25	TreatmentAdministeredForProblem Treatment:T51 Prob:T346	
R26	TreatmentAdministeredForProblem Treatment:T52 Prob:T346	
R27	TreatmentAdministeredForProblem Treatment:T53 Prob:T346	
T347	GenomicTest 2142 2157	genetic testing
A112	TreatmentContinuityVal T347 continuing
A113	TreatmentTypeVal T347 others
A114	TreatmentIntentVal T347 others
A115	TreatmentCategory T347 Supportive
A116	IntentVal T347 others
A117	GenomicTestType T347 Germline
T348	GenomicTestResult 2195 2202	ATM VUS
A118	GenomicTestType T348 Germline
R28	ResultOfTest Desc:T348 Test:T347	
T349	ClinicalCondition 2255 2267	Hypertension
A119	ChronicVal T349 chronic
A120	ContinuityVal T349 stable
A121	ChronicVal T56 chronic
A122	ContinuityVal T56 stable
A123	ChronicVal T57 chronic
A124	ContinuityVal T57 stable
T350	ClinicalCondition 2349 2368	psoriatic arthritis
A125	ChronicVal T350 chronic
A126	ContinuityVal T350 stable
T351	ClinicalCondition 2337 2347	depression
A127	ChronicVal T351 chronic
A128	ContinuityVal T351 stable
T352	ClinicalCondition 2381 2394	alcohol abuse
A129	ChronicVal T352 chronic
A130	ContinuityVal T352 stable
T353	ClinicalCondition 2396 2417	restless leg syndrome
A131	ChronicVal T353 chronic
A132	ContinuityVal T353 stable
T354	ClinicalCondition 2419 2423	GERD
A133	ChronicVal T354 chronic
A134	ContinuityVal T354 stable
T355	ClinicalCondition 2436 2455	Barrett's esophagus
A135	ChronicVal T355 chronic
A136	ContinuityVal T355 stable
T356	ClinicalCondition 2466 2472	stroke
A137	ChronicVal T356 chronic
A138	ContinuityVal T356 stable
A139	NegationModalityVal T356 uncertain_in_past
T357	ClinicalCondition 2480 2506	MRSA infection right elbow
A140	ChronicVal T357 chronic
A141	ContinuityVal T357 stopped
T358	ClinicalCondition 2534 2553	Metatarsal fracture
A142	IntentVal T358 others
A143	TreatmentTypeVal T358 others
A144	TreatmentCategory T358 Others
T359	ProcedureName 2617 2633	knee replacement
A145	IntentVal T359 others
A146	TreatmentTypeVal T359 others
A147	TreatmentCategory T359 Others
T360	ClinicalCondition 2670 2687	clavicle fracture
A148	IntentVal T360 others
A149	TreatmentTypeVal T360 others
A150	TreatmentCategory T360 Others
A151	ChronicVal T360 non-chronic
A152	ContinuityVal T360 stopped
A153	ChronicVal T358 non-chronic
A154	ContinuityVal T358 stopped
A155	ChronicVal T359 non-chronic
A156	ContinuityVal T359 stopped
T361	ClinicalCondition 2649 2663	MRSA infection
A157	ChronicVal T361 non-chronic
A158	ContinuityVal T361 stopped
R29	ConditionOrTreatmentCausesProblem Treatment:T359 Prob:T361	
T362	Datetime 2474 2478	2021
R30	HappensAtOnDuring Arg1:T362 Arg2:T356	
T363	Datetime 2508 2512	2010
R31	HappensAtOnDuring Arg1:T363 Arg2:T357	
T364	ProcedureName 2564 2571	surgery
A159	IntentVal T364 others
A160	TreatmentTypeVal T364 others
A161	TreatmentCategory T364 Others
R32	TestOrProcedureConductedForProblem Test:T364 Prob:T358	
T365	ProcedureName 2576 2597	placement of hardware
A162	IntentVal T365 others
A163	TreatmentTypeVal T365 others
A164	TreatmentCategory T365 Others
R33	TestOrProcedureConductedForProblem Test:T365 Prob:T358	
T366	ProcedureName 2698 2706	surgery,
A165	IntentVal T366 others
A166	TreatmentTypeVal T366 others
A167	TreatmentCategory T366 Others
R34	TestOrProcedureConductedForProblem Test:T366 Prob:T360	
T367	ProcedureName 2713 2722	C-section
A168	IntentVal T367 others
A169	TreatmentTypeVal T367 others
A170	TreatmentCategory T367 Others
T368	Datetime 2599 2603	2010
T369	Datetime 2707 2711	2001
T370	Datetime 2724 2728	1995
R35	HappensAtOnDuring Arg1:T370 Arg2:T367	
R36	HappensAtOnDuring Arg1:T369 Arg2:T366	
R37	HappensAtOnDuring Arg1:T368 Arg2:T365	
R38	HappensAtOnDuring Arg1:T368 Arg2:T364	
R39	HappensAtOnDuring Arg1:T368 Arg2:T358	
R40	HappensAtOnDuring Arg1:T369 Arg2:T359	
T371	Laterality 2605 2610	right
T372	Laterality 2665 2669	left
T373	SectionSkip 2797 3886;3889 5842;5845 7036	CURRENT MEDICATIONS:  Current Outpatient Medications on File Prior to Visit   Medication Sig Dispense Refill    albuterol 90 mcg/actuation metered dose inhaler Inhale 2 puffs into the lungs every 4 (four) hours as needed    (Patient not taking: Reported on 06/20/2022)      buPROPion 450 mg TABSR24H Take 450 mg by mouth daily      capecitabine (XELODA) 500 mg tablet Take 3 tabs with food in the morning, and take 3 tabs with food in the evening. Take for 7 days and then off for 7 days. (Patient not taking: Reported on 06/20/2022) 84 tablet 5    clonazePAM (KLONOPIN) 1 mg tablet Take 1 mg by mouth 2 (two) times daily as needed      clotrimazole (LOTRIMIN) 1 % cream Apply topically Twice a day Use as instructed apply to sides of mouth/lips      cyanocobalamin 2,500 mcg SL tablet 2,500 mcg      cyclobenzaprine (FLEXERIL) 10 mg tablet   1 Tab, PO TID, PRN AS NEEDED, Qty: 90 Tab, Refills: 2, ***** ***** ***** Electronically, ***** ***** *****, 30      diclofenac (VOLTAREN) 1 % gel Apply topically 4 (four) times daily as needed      etodolac (*****) 400 mg tablet Take 400 mg by mouth 2 (two) times daily      famotidine (PEPCID) 20 mg tablet Take 1 tablet (20 mg total) by mouth in the morning and 1 tablet (20 mg total) in the evening. (Patient taking differently: Take 40 mg by mouth in the morning and 40 mg at noon and 40 mg in the evening.) 180 tablet 2    FLUoxetine (PROZAC) 40 mg capsule Take 40 mg by mouth daily      fluticasone propionate (FLOVENT DISKUS INH) Inhale into the lungs (Patient not taking: Reported on 06/20/2022)      gabapentin (NEURONTIN) 300 mg capsule Take 1,200 mg by mouth 2 (two) times daily      hydrocortisone 2.5 % ointment Apply topically 4 (four) times daily      levocarnitine HCl (ACETYL-L-CARNITINE MISC) Take 1 tablet by mouth daily      lidocaine-diphenhydrAMINE-maalox (MAGIC MOUTHWASH) mouthwash Use as directed 10 mL in the mouth or throat in the morning and 10 mL at noon and 10 mL in the evening and 10 mL before bedtime. For mouth sores.. 480 mL 1    lipase-protease-amylase (CREON) 24,000-76,000 -120,000 unit capsule Take 1 to 2 caps with meals, take 1 cap with snacks 180 capsule 11    loperamide (IMODIUM) 2 mg capsule Take two capsules by mouth at the onset of diarrhea, then take one capsule every 2 hours until diarrhea-free for 12 hours. (Patient not taking: Reported on 06/20/2022) 30 capsule 5    LORazepam (ATIVAN) 1 mg tablet Take 1 mg by mouth nightly as needed for Anxiety         losartan (COZAAR) 50 mg tablet Take 50 mg by mouth every evening (Patient not taking: Reported on 06/20/2022)      montelukast (SINGULAIR) 10 mg tablet Take 10 mg by mouth daily      multivitamin tablet Take 1 tablet by mouth daily      naloxone 4 mg/actuation SPRAYNAERO 1 spray by Nasal route once as needed (suspected overdose) for up to 1 dose Call 911. Repeat if needed (Patient not taking: Reported on 06/20/2022) 2 each 0    ondansetron (ZOFRAN) 8 mg tablet Take 1 tablet (8 mg total) by mouth every 8 (eight) hours as needed (nausea and vomiting) (Patient not taking: Reported on 06/20/2022) 30 tablet 5    oxyCODONE (ROXICODONE) 5 mg tablet Take 1 tablet (5 mg total) by mouth every 8 (eight) hours as needed for Pain (Pain not relieved by gabapentin, tylenol or ibuprofen) (Patient not taking: Reported on 06/20/2022) 10 tablet 0    polyethylene glycol (MIRALAX) 17 gram packet Take 17 g by mouth as needed in the morning (constipation). (Patient not taking: Reported on 06/20/2022)      prochlorperazine (COMPAZINE) 10 mg tablet Take 1 tablet (10 mg total) by mouth every 6 (six) hours as needed (nausea and vomiting) (Patient not taking: Reported on 06/20/2022) 30 tablet 5    rOPINIRole (REQUIP) 1 mg tablet Take 1 mg by mouth nightly at bedtime      tamsulosin (FLOMAX) 0.4 mg 24 hr capsule Take 1 capsule (0.4 mg total) by mouth daily 30 capsule 1    thyroid, porcine, (ARMOUR) 120 mg tablet 120 mg daily      UNABLE TO FIND 28 mg daily Med Name: ferrous  bis-glycinate      VITAMIN B-1, MONONITRATE, 100 mg tablet Take 100 mg by mouth daily (Patient not taking: Reported on 06/20/2022)      zolpidem (AMBIEN) 10 mg tablet Take 10 mg by mouth nightly as needed       No current facility-administered medications on file prior to visit.
A171	SectionSkipType T373 medications
T374	SectionSkip 7041 7146	ALLERGIES:  Allergies/Contraindications   Allergen Reactions    Sulfa (Sulfonamide Antibiotics) Swelling
A172	SectionSkipType T374 allergies
T375	ClinicalCondition 7232 7245	breast cancer
A173	ChronicVal T375 chronic
A174	ExperiencerVal T375 family
T376	Age 7269 7272	80s
R41	BeginsOnOrAt Arg1:T376 Arg2:T375	
T377	MaritalStatus 7354 7363	separated
A175	IsStoppedOrContinuing T377 stopped
T378	Alcohol 7435 7448	alcohol abuse
A176	NegationModalityVal T378 affirmed
T379	Tobacco 7459 7474	chewing tobacco
A177	IsStoppedOrContinuing T379 stopped
T380	ConsumptionQuantity 7506 7514	10 years
R42	ConsumptionQuantityRel Arg1:T380 Arg2:T379	
T381	ClinicalCondition 7620 7629	arthritis
A178	ChronicVal T381 chronic
A179	ContinuityVal T381 unclear
T382	SectionSkip 7636 7732	PE:    Vitals: There were no vitals taken for this visit.   In general, she appears comfortable.
A180	SectionSkipType T382 physical_exam
T383	SectionSkip 7738 7787;7790 9233	LABORATORY RESULTS:  Results for orders placed or performed in visit on 06/21/22   Comprehensive Metabolic Panel, Random (BMP, AST, ALT, T.BILI, ALKP, TP, ALB)   Result Value Ref Range    Albumin, Serum / Plasma 3.4 3.4 - 4.8 g/dL    Alkaline Phosphatase 151 (H) 38 - 108 U/L    Alanine transaminase 29 10 - 61 U/L    AST 24 5 - 44 U/L    Bilirubin, Total 0.3 0.2 - 1.2 mg/dL    Urea Nitrogen, Serum / Plasma 12 7 - 25 mg/dL    Calcium, total, Serum / Plasma 9.3 8.4 - 10.5 mg/dL    Chloride, Serum / Plasma 99 (L) 101 - 110 mmol/L    Creatinine 0.82 0.55 - 1.02 mg/dL    ***** 79 >59 mL/min/1.73m2    Potassium, Serum / Plasma 5.3 (H) 3.5 - 5.0 mmol/L    Sodium, Serum / Plasma 129 (L) 135 - 145 mmol/L    Protein, Total, Serum / Plasma 6.8 6.3 - 8.6 g/dL    Carbon Dioxide, Total 25 22 - 29 mmol/L    Anion Gap 5 4 - 14    Glucose, non-fasting 109 70 - 199 mg/dL   Complete Blood Count with 5-part Differential   Result Value Ref Range    WBC Count 11.7 (H) 3.4 - 10.0 x10E9/L    RBC Count 3.34 (L) 4.00 - 5.20 x10E12/L    Hemoglobin 11.5 (L) 12.0 - 15.5 g/dL    Hematocrit 34.3 (L) 36.0 - 46.0 %    MCV 103 (H) 80 - 100 fL    MCH 34.4 (H) 26.0 - 34.0 pg    MCHC 33.5 31.0 - 36.0 g/dL    Platelet Count 485 (H) 140 - 450 x10E9/L    Abs Neutrophils 5.24 1.80 - 6.80 x10E9/L    Abs Lymphocytes 2.75 1.00 - 3.40 x10E9/L    Abs Monocytes 2.59 (H) 0.20 - 0.80 x10E9/L    Abs Eosinophils 0.93 (H) 0.00 - 0.40 x10E9/L    Abs Basophils 0.04 0.00 - 0.10 x10E9/L    Abs Imm Granulocytes 0.13 (H) <0.10
A181	SectionSkipType T383 laboratory
T384	SectionSkip 9248 9751;9754 11714;11717 12259	IMAGING:  CT Abdomen /Pelvis with Contrast    Result Date: 06/19/2022  CT ABDOMEN/PELVIS WITH CONTRAST  *****/*****/***** *****:***** PM CLINICAL HISTORY: surveillance scan h/o pancreatic cancer COMPARISON:  CT abdomen/pelvis 04/11/2022 TECHNIQUE: CT of the abdomen and pelvis was performed. MEDICATIONS: Iohexol 350 - 110 mL - Intravenous RADIATION DOSE INDICATORS: ***** *****: 3 , CTDIvol Min: 7.9 mGy, CTDIvol Max: 7.9 mGy, DLP: 504.5 mGy.cm. The following accession numbers are related to this dose report *****,***** FINDINGS: Visualized lung bases:  For chest findings, please see the separately dictated report from the CT of the chest of the same date. Liver:  Unremarkable Gallbladder: Unremarkable Spleen:  Status post splenectomy. Pancreas:  Expected postsurgical changes related to prior distal pancreatectomy of the body and tail. Adrenal Glands:  Unremarkable Kidneys: Subcentimeter bilateral hypodensities too small to definitively characterize, likely cysts, unchanged. GI Tract:  Small hiatal hernia, unchanged. Vasculature:  - Decrease in stranding surrounding the celiac axis and branches, reflecting expected postoperative changes. - Interval resolution of previously noted narrowing of the junction of the portal vein and superior mesenteric vein. - Mild atherosclerotic disease of the abdominal aorta and its branches. Lymphadenopathy: Unchanged gastrohepatic lymph node measuring 9 x 7 mm, may be reactive secondary to prior surgery. Peritoneum: No ascites. Interval resolution of previously seen trace free fluid adjacent to the cut edge of pancreas. Bladder: Unremarkable Reproductive organs: Intrauterine device in place. Leiomyoma. Bones:  No suspicious lesions. Redemonstrated bilateral pars defects at L5, and degenerative disc disease at L5/S1 with grade 1 anterolisthesis. Extraperitoneal soft tissues: Unremarkable Lines/drains/medical devices: As above     1. Expected postsurgical changes related to prior distal pancreatectomy of the body and tail. 2. No evidence of metastatic disease in the abdomen or pelvis. Report dictated by: ***** *****, MD, signed by: ***** *****-***** *****, MD Department of Radiology and Biomedical Imaging    CT Chest with Contrast    Addendum Date: 06/19/2022    //Segmental/subsegmental right lower lobe pulmonary embolism discussed with Ong, RN by ***** ***** *****, MD (Radiology) on *****/*****/***** *****:***** PM.// Report dictated by: ***** ***** *****, MD, signed by: ***** ***** *****, MD Department of Radiology and Biomedical Imaging    Result Date: 06/19/2022  CT CHEST WITH CONTRAST CLINICAL HISTORY:  Pancreatic cancer, primary surveillance scan COMPARISON: CT chest dated 02/10/2022 TECHNIQUE: Serial 1.25 mm axial images through the chest were obtained after the administration of intravenous contrast. Iohexol 350 - 110 mL - Intravenous RADIATION DOSE INDICATORS: Exposure Events: 3 , CTDIvol Min: 7.9 mGy, CTDIvol Max: 7.9 mGy, DLP: 504.5 mGy.cm. The following accession numbers are related to this dose report *****,*****
A182	SectionSkipType T384 radiology_report
T385	Histology 13115 13129	Adenocarcinoma
A183	EpisodeDescription T385 Others
T386	Site 13137 13157	tail of the pancreas
T387	ProcedureName 13171 13192	distal pancreatectomy
A184	IntentVal T387 treatment-curative
A185	TreatmentTypeVal T387 local
A186	TreatmentCategory T387 AntiNeoPlastics
A187	IsTumorRemaining T387 no
T388	ProcedureName 13197 13208	splenectomy
A188	IntentVal T388 treatment-curative
A189	TreatmentTypeVal T388 local
A190	TreatmentCategory T388 AntiNeoPlastics
A191	IsTumorRemaining T388 no
T389	LymphNodeInvolvement 13214 13222	positive
A192	NegationModalityVal T389 affirmed
A193	EpisodeDescription T389 FirstOccurrence
A194	ChronicVal T274 chronic
A195	ContinuityVal T274 stable
A196	ChronicVal T276 chronic
A197	ContinuityVal T276 stable
A198	ChronicVal T279 non-chronic
A199	ContinuityVal T279 unclear
A200	ChronicVal T280 non-chronic
A201	ContinuityVal T280 unclear
A202	ChronicVal T275 chronic
A203	ContinuityVal T275 stable
T390	ClinicalCondition 13311 13325	MRSA infection
A204	ChronicVal T390 non-chronic
A205	ContinuityVal T390 stopped
T391	ClinicalCondition 13470 13488	hand-foot syndrome
A206	ChronicVal T391 non-chronic
A207	ContinuityVal T391 worsening
T392	ClinicalCondition 13493 13502	mucositis
A208	ChronicVal T392 non-chronic
A209	ContinuityVal T392 worsening
T393	TreatmentType 13516 13528	chemotherapy
A210	TreatmentContinuityVal T393 discontinued_early
A211	TreatmentTypeVal T393 adjuvant
A212	TreatmentIntentVal T393 curative
R43	TreatmentDiscontinuedBecauseOf Therapy:T393 Reason:T392	
R44	TreatmentDiscontinuedBecauseOf Therapy:T393 Reason:T391	
T394	TreatmentType 13564 13576	chemotherapy
A213	TreatmentContinuityVal T394 discontinued_early
A214	TreatmentTypeVal T394 adjuvant
A215	TreatmentIntentVal T394 curative
T395	ClinicalCondition 13609 13627	hand-foot syndrome
A216	ChronicVal T395 non-chronic
A217	ContinuityVal T395 worsening
R45	TreatmentDiscontinuedBecauseOf Therapy:T394 Reason:T395	
T396	Radiology 13735 13737	CT
A218	IntentVal T396 others
T397	Symptom 13710 13715	falls
A219	IsPresentOnFirstCancerDiagnosis T397 no
A220	IsCausedByDiagnosedCancer T397 no
A221	ChronicVal T397 non-chronic
A222	ContinuityVal T397 worsening
R46	TestOrProcedureConductedForProblem Test:T396 Prob:T397	
T398	MedicationName 13797 13809	capecitabine
A223	TreatmentContinuityVal T398 discontinued_early
A224	TreatmentTypeVal T398 adjuvant
A225	TreatmentIntentVal T398 curative
A226	TreatmentCategory T398 AntiNeoPlastics
T399	Symptom 13831 13847	balance disorder
A227	IsPresentOnFirstCancerDiagnosis T399 no
A228	IsCausedByDiagnosedCancer T399 no
A229	ContinuityVal T399 worsening
R47	TreatmentDiscontinuedBecauseOf Therapy:T398 Reason:T399	
T400	ClinicalCondition 13980 13982	PE
A230	ChronicVal T400 non-chronic
A231	ContinuityVal T400 stable
T401	MedicationName 14005 14012	Lovenox
A233	TreatmentTypeVal T401 others
A234	TreatmentIntentVal T401 others
A235	TreatmentCategory T401 Others
R48	TreatmentAdministeredForProblem Treatment:T401 Prob:T400	
T402	ClinicalCondition 14070 14073	DVT
A236	NegationModalityVal T402 uncertain_in_present
A237	ChronicVal T402 non-chronic
A238	ContinuityVal T402 unclear
T403	Radiology 14031 14039	Dopplers
A239	IntentVal T403 diagnosis
R49	TestOrProcedureConductedForProblem Test:T403 Prob:T402	
T404	MedicationName 14106 14113	Lovenox
A232	TreatmentTypeVal T404 others
A240	TreatmentIntentVal T404 others
A241	TreatmentCategory T404 Others
R50	TestOrProcedureReveals Test:T314 Desc:T318	
R51	SiteOf Arg1:T386 Arg2:T385	
R52	TestOrProcedureReveals Test:T314 Desc:T320	
R53	ConditionOrTreatmentCausesProblem Treatment:T322 Prob:T324	
R54	ConditionOrTreatmentCausesProblem Treatment:T322 Prob:T325	
R55	ConditionOrTreatmentCausesProblem Treatment:T322 Prob:T326	
R56	ConditionOrTreatmentCausesProblem Treatment:T322 Prob:T327	
R57	TreatmentDiscontinuedBecauseOf Therapy:T328 Reason:T326	
R58	TreatmentDiscontinuedBecauseOf Therapy:T328 Reason:T327	
R59	TreatmentDiscontinuedBecauseOf Therapy:T328 Reason:T324	
R60	TreatmentDiscontinuedBecauseOf Therapy:T328 Reason:T325	
R61	ConditionOrTreatmentCausesProblem Treatment:T328 Prob:T326	
R62	ConditionOrTreatmentCausesProblem Treatment:T328 Prob:T327	
R63	ConditionOrTreatmentCausesProblem Treatment:T328 Prob:T324	
R64	ConditionOrTreatmentCausesProblem Treatment:T328 Prob:T325	
R65	ConditionOrTreatmentCausesProblem Treatment:T331 Prob:T336	
R66	ConditionOrTreatmentCausesProblem Treatment:T331 Prob:T337	
T405	TreatmentDoseModification 1615 1632	dose modification
A242	NegationModalityVal T405 negated
R67	TreatmentDesc Therapy:T405 Desc:T339	
T406	SDoH 1767 1773	walker
A243	IsStoppedOrContinuing T406 continuing
A244	ExperiencerVal T406 patient
T407	Symptom 1803 1809	sleeps
A245	ChronicVal T407 non-chronic
A246	ContinuityVal T407 worsening
T408	PhysicalActivity 1909 1926	walk a few blocks
A247	IsStoppedOrContinuing T408 continuing
T409	Symptom 2020 2028	appetite
A248	NegationModalityVal T409 negated
T410	Symptom 2053 2068	lost any weight
A249	NegationModalityVal T410 negated
T411	Symptom 2091 2114	2 loose bowel movements
T412	ClinicalCondition 2743 2758	Broken clavicle
A250	ChronicVal T412 non-chronic
A251	ContinuityVal T412 stopped
T413	LivingCondition 7298 7319	lives with her sister
T414	PatientCharacteristics 7339 7345	2 sons
T415	PhysicalActivity 7542 7553	very active
T416	Employment 7401 7406	teach
A252	IsStoppedOrContinuing T416 stopped
R68	TestOrProcedureReveals Test:T387 Desc:T385	
R69	TestOrProcedureReveals Test:T387 Desc:T389	
R70	ConditionOrTreatmentCausesProblem Treatment:T393 Prob:T392	
R71	ConditionOrTreatmentCausesProblem Treatment:T393 Prob:T391	
R72	ConditionOrTreatmentCausesProblem Treatment:T398 Prob:T399	
T417	RadPathResult 13759 13771	unremarkable
A253	RadPathResultVal T417 Others
R73	ResultOfTest Desc:T417 Test:T396	
A254	TreatmentContinuityVal T401 started
A255	TreatmentContinuityVal T404 started
T418	hpi_start 2 12	SUBJECTIVE
T419	hpi_end 2199 2203	VUS.
T420	ap_start 13099 13109	ASSESSMENT
T421	ap_end 14133 14140	before.
